ZMIZ2 and non-small cell lung carcinoma: Elevated nuclear ZMIZ2 expression was significantly associated with advanced p-TNM staging (P = 0.028), lymph node metastasis (P = 0.016), and poor overall survival (P = 0.001) in NSCLC (Fig. 1E, Table 2).